Search | IOVS | ARVO Journals

Showing 1 – 20 of 25

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Global methylation status of induced pluripotent stem cells, their origins and final differentiations

Christina Kiel; Patricia Berber; Karolina Plössl; Armin Wolf; Thomas Langmann; Bernhard HF Weber

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3734 – F0340. doi:

ARVO Annual Meeting Abstract June 2022

Disturbances of the retinal endothelial cells’ barrier induced by long-term treatment with VEGFA 165 are independent of the growth factor’s action

Heidrun L Deissler; Matus Rehak; Armin Wolf

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3587 – A0042. doi:

ARVO Annual Meeting Abstract June 2021

Brolucizumab’s actions on unchallenged or VEGFA-exposed retinal endothelial cells

Heidrun L Deissler; Catharina Busch; Armin Wolf; Matus Rehak

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):188. doi:

ARVO Annual Meeting Abstract July 2019

Subthreshold laser treatment in chronic central serous chorioretinopathy: 3-month results from a prospective interventional study.

Benedikt Schworm; Leonie Keidel; Maximilian Gerhard; Tina Herold; Armin Wolf; Siegfried Priglinger; Nikolaus Luft

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3677. doi:

ARVO Annual Meeting Abstract July 2019

Human recombinant Galectin-1 mitigates the cellular mechanisms of proliferative vitreoretinopathy in primary human tractive membranes in-vitro

Annabel von Studnitz; Christian Wertheimer; Anna Hillenmayer; Arie Geerlof; Stefan Kassumeh; Siegfried Priglinger; Armin Wolf; Claudia Priglinger

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6417. doi:

ARVO Annual Meeting Abstract July 2019

Visual outcome of multifocal intraocular lenses after retinal detachment surgery

Sigrid Barbara Freissinger; Armin Wolf; Iris Bayer; Christoph Kern; Siegfried Priglinger; Leonie Franziska Keidel; Mehdi Shajari; Thomas Kreutzer; Efstathios Vounotrypidis

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6595. doi:

Lens December 2017

The Intraocular Lens as a Drug Delivery Device: In Vitro Screening of Pharmacologic Substances for the Prophylaxis of Posterior Capsule Opacification

PDF

Christian Wertheimer; Stefan Kassumeh; Nick P. Piravej; Olga Nilmayer; Christian Braun; Claudia Priglinger; Nikolaus Luft; Armin Wolf; Wolfgang J. Mayer; Siegfried G. Priglinger; Kirsten H. Eibl-Lindner
TAGS: after-cataract, drug delivery systems, intraocular lens implant device, methotrexate, pharmacology, prevention, screening, toxic effect, rapamycin, esters
Invest. Ophthalmol. Vis. Sci.. 2017; 58(14):6408-6418. doi: https://doi.org/10.1167/iovs.17-22555

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2017

Ranibizumab in pigment epithelial tears secondary to AMD – a prospective, multicenter, investigator-initiated trial (RIP Study)

Tim U Krohne; Petra P Fang; Akio Oishi; Seleman Bedar; Philipp K. R. Heymer; Christoph Roman Clemens; Susanna König; Nicole Eter; Armin Wolf; Frank G Holz

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3763. doi:

ARVO Annual Meeting Abstract September 2016

Single volume widefield retinal and choroidal OCT angiography of patients with MHz-OCT over 45° field of view

Jan Philip Kolb; Thomas Klein; Kathrin J. Mohler; Wolfgang Wieser; Aljoscha S. Neubauer; Marcus Kernt; Anselm Kampik; Armin Wolf; Robert Huber

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):443. doi:

Multidisciplinary Ophthalmic Imaging October 2015

Combined 60° Wide-Field Choroidal Thickness Maps and High-Definition En Face Vasculature Visualization Using Swept-Source Megahertz OCT at 1050 nm

PDF

Kathrin J. Mohler; Wolfgang Draxinger; Thomas Klein; Jan Philip Kolb; Wolfgang Wieser; Christos Haritoglou; Anselm Kampik; James G. Fujimoto; Aljoscha S. Neubauer; Robert Huber; Armin Wolf
TAGS: choroid, diagnostic imaging, face, maps, vasculature, summation
Invest. Ophthalmol. Vis. Sci.. 2015; 56(11):6284-6293. doi: https://doi.org/10.1167/iovs.15-16670

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2015

Monthly treatment of ranibizumab in vascular pigment epithelium detachment due to age-related macular degeneration

Christoph Roman Clemens; Florian Alten; Armin Wolf; Caroline Milojcic; Nicole Eter

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2838. doi:

ARVO Annual Meeting Abstract April 2014

Wide-field choroidal thickness and en-face maps of patients created with MHz-OCT

Thomas Klein; Wolfgang Draxinger; Kathrin Mohler; Jan Philip Kolb; Wolfgang Wieser; Anselm Kampik; Aljoscha S Neubauer; Armin Wolf; Robert Huber

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1620. doi:

ARVO Annual Meeting Abstract June 2013

EGF-Receptor inhibitor Gefitinib as a potential pharmacological prophylaxis for posterior capsule opacification

Peter Laubichler; Christian Wertheimer; Raffael Liegl; Marcus Kernt; Armin Wolf; Christos Haritoglou; Anselm Kampik; Kirsten Eibl-Lindner

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2956. doi:

ARVO Annual Meeting Abstract June 2013

APC-Coated Intraocular Lenses Reduce the Occurrence of PCO in a Human Anterior Chamber Model

Raffael Liegl; Christian Wertheimer; Marcus Kernt; Armin Wolf; Anselm Kampik; Kirsten Eibl-Lindner

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5946. doi:

ARVO Annual Meeting Abstract March 2012

Retinal Navigated Laser (Navilas®) Compared Versus Conventional Laser In Diabetic Macular Edema

Marcus Kernt; Igor Kozak; Florian Seidensticker; Aljoscha S. Neubauer; Armin Wolf; Michael W. Ulbig; William R. Freeman; Anselm Kampik

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):384. doi:

ARVO Annual Meeting Abstract March 2012

A Comparison of Intravitreal Bevacizumab Up-load Followed by a dexamethasone-implant versus dexamethasone-implant Mono Therapy for Retinal Vein Occlusion with Macular Edema

Wolfgang J. Mayer; Armin Wolf; Lukas Reznicek; Daniel Kook; Anselm Kampik; Michael Ulbig; Christos Haritoglou

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):915. doi:

ARVO Annual Meeting Abstract March 2012

EGF-Receptor Inhibitor Erlotinib As A Potential Pharmacological Prophylaxis For Posterior Capsule Opacification

Christian M. Wertheimer; Raffael Liegl; Marcus Kernt; Armin Wolf; Denitsa Docheva; Christos Haritoglou; Anselm Kampik; Kirsten H. Eibl

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3047. doi:

ARVO Annual Meeting Abstract March 2012

Idebenone Prevents Retinal Pigmentepithelium (RPE) Cells from Oxidative Stress and Senescence

Nicole Arend; Susanna Koenig; Peter Laubichler; Armin Wolf; Christos Haritoglou; Michael W. Ulbig; Anselm Kampik; Marcus Kernt

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6887. doi:

ARVO Annual Meeting Abstract March 2012

Inhibiton Of Human Lens Epithelial Cell Contraction By Alkylphosphocholines For PCO Prophylaxis And Downregulation Of The PI3K Pathway

Raffael Liegl; Marcus Kernt; Armin Wolf; Daniel Kook; Christos Haritoglou; Anselm Kampik; Kirsten H. Eibl-Lindner

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6909. doi:

Retina August 2011

Inhibition of TLR3-Mediated Proinflammatory Effects by Alkylphosphocholines in Human Retinal Pigment Epithelial Cells

PDF

Markus Wörnle; Monika Merkle; Armin Wolf; Andrea Ribeiro; Susanne Himmelein; Marcus Kernt; Anselm Kampik; Kirsten H. Eibl-Lindner
TAGS: chemokines, cytokine, retinal pigment cell, rna, reverse transcriptase polymerase chain reaction, fibroblast growth factor 2, intercellular adhesion molecule 1, receptors, virus, rna, messenger, tumor necrosis factors
Invest. Ophthalmol. Vis. Sci.. 2011; 52(9):6536-6544. doi: https://doi.org/10.1167/iovs.10-6993

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Global methylation status of induced pluripotent stem cells, their origins and final differentiations

Disturbances of the retinal endothelial cells’ barrier induced by long-term treatment with VEGFA 165 are independent of the growth factor’s action

Brolucizumab’s actions on unchallenged or VEGFA-exposed retinal endothelial cells

Subthreshold laser treatment in chronic central serous chorioretinopathy: 3-month results from a prospective interventional study.

Human recombinant Galectin-1 mitigates the cellular mechanisms of proliferative vitreoretinopathy in primary human tractive membranes in-vitro

Visual outcome of multifocal intraocular lenses after retinal detachment surgery

The Intraocular Lens as a Drug Delivery Device: In Vitro Screening of Pharmacologic Substances for the Prophylaxis of Posterior Capsule Opacification

Ranibizumab in pigment epithelial tears secondary to AMD – a prospective, multicenter, investigator-initiated trial (RIP Study)

Single volume widefield retinal and choroidal OCT angiography of patients with MHz-OCT over 45° field of view

Combined 60° Wide-Field Choroidal Thickness Maps and High-Definition En Face Vasculature Visualization Using Swept-Source Megahertz OCT at 1050 nm

Monthly treatment of ranibizumab in vascular pigment epithelium detachment due to age-related macular degeneration

Wide-field choroidal thickness and en-face maps of patients created with MHz-OCT

EGF-Receptor inhibitor Gefitinib as a potential pharmacological prophylaxis for posterior capsule opacification

APC-Coated Intraocular Lenses Reduce the Occurrence of PCO in a Human Anterior Chamber Model

Retinal Navigated Laser (Navilas®) Compared Versus Conventional Laser In Diabetic Macular Edema

A Comparison of Intravitreal Bevacizumab Up-load Followed by a dexamethasone-implant versus dexamethasone-implant Mono Therapy for Retinal Vein Occlusion with Macular Edema

EGF-Receptor Inhibitor Erlotinib As A Potential Pharmacological Prophylaxis For Posterior Capsule Opacification

Idebenone Prevents Retinal Pigmentepithelium (RPE) Cells from Oxidative Stress and Senescence

Inhibiton Of Human Lens Epithelial Cell Contraction By Alkylphosphocholines For PCO Prophylaxis And Downregulation Of The PI3K Pathway

Inhibition of TLR3-Mediated Proinflammatory Effects by Alkylphosphocholines in Human Retinal Pigment Epithelial Cells

To View More...

You must be signed into an individual account to use this feature.